Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Amgen Inc. v. apotex Inc., No. 16-1308 (Fed. Cir. July 5, 2016)

Errata Correction sheet to a previously issued opinion
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1308
Decided
July 5, 2016
Judge
Document
Errata
Length
1 page

United States Court of Appeals

for the Federal Circuit

July 6, 2016 ERRATUM

Appeal No. 2016-1308 AMGEN INC., AMGEN MANUFACTURING

LIMITED,

Plaintiffs-Appellees

v.

APOTEX INC., APOTEX CORP.,

Defendants-Appellants Decided: July 5, 2016 Precedential Opinion The following change has been made: On page 5, line 22 of the opinion, change “short-hand” to “shorthand.”

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Amgen Inc. v. apotex Inc., No. 16-1308 (Fed. Cir. July 5, 2016).

govinfo ID
USCOURTS-ca13-16-01308-1
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-16-01308-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.